Merck VS Mylan Pharma: US Court of Appeals for the Federal Circuit rules in favor of Merck in Sitagliptin Dihydrogen Phosphate patent lawsuit Ruchika Sharma2 Oct 2022 5:00 PM ISTThe ruling from the U.S. Court of Appeals provides JANUVIA, JANUMET and JANUMET XR patent protection through May 2027, which includes six (6) months...
AstraZeneca, Merck get Chinese nod for Lynparza to treat ovarian cancer Ruchika Sharma24 Sept 2022 3:24 PM ISTIn China, Lynparza is approved for the treatment of BRCA-mutated metastatic castration-resistant prostate cancer as well as a 1st-line maintenance...
AstraZeneca Lynparza shows clinically meaningful survival benefit in 1st-line advanced ovarian cancer across two Phase III trials Ruchika Sharma11 Sept 2022 1:15 PM ISTOvarian cancer is one of the most common gynaecologic cancers, with a poor prognosis and a high mortality rate.
AstraZeneca, MSD get Japenese nod for breast cancer drug Lynparza Ruchika Sharma28 Aug 2022 11:45 AM ISTBreast cancer is the most diagnosed cancer worldwide with an estimated 2.3 million patients diagnosed in 2020.
Merck, Illumina launch research test to unlock deeper insights into tumor genome Ruchika Sharma25 Jun 2022 9:00 AM ISTThe Research Use Only TruSight Oncology 500 HRD test is a next-generation sequencing (NGS)–based assay.
Merck presents positive results from Pneumococcal conjugate vaccine study Ruchika Sharma22 Jun 2022 2:30 PM ISTPneumococcal disease is an infection caused by the bacterium Streptococcus pneumoniae, or pneumococcus.
HealthQuad closes second fund, raised Rs 1215 crores, led by global pharma giant MSD MD Bureau31 March 2022 5:32 PM ISTHealthQuad, India's leading healthcare venture capital fund, has announced the final close of its second fund, HealthQuad Fund-II, with a total...
Vietnam says Pfizer, MSD to grant its firms licenses to produce COVID pills Medical Dialogues Bureau26 Nov 2021 11:45 AM ISTHanoi: Drugmakers Pfizer Inc and MSD, known as Merck & Co Inc in North America, have agreed to give licenses to firms in Vietnam to produce...
Sun Pharma to launch Molnupiravir under brand name Molxvir in India Ruchika Sharma12 Nov 2021 12:00 PM ISTMumbai: Sun Pharmaceutical Industries Limited has recently said that the company is gearing up to introduce Merck Sharpe Dohme (MSD) and Ridgeback's...
Patent Infringement: MSD sues firm in Delhi HC over diabetes drug Sitagliptin Medical Dialogues Team20 Jun 2021 11:30 AM ISTNew Delhi: In a major victory for Merck Sharp and Dohme (MSD) Corp, the Delhi High Court has restrained Solitaire Pharmacia Private from infringing...
Delhi HC Restrains Firm From Infringing on MSD Diabetes Drug Sitagliptin Medical Dialogues Team8 Jun 2021 8:36 PM ISTNew Delhi: In a major relief to Merck Sharp & Dohme Corp, the Delhi High Court has barred YMS Laboratories Private Limited from infringing on...
Merck inks licensing pact with Cipla, Sun Pharma, 3 others for oral COVID drug Molnupiravir Medical Dialogues Team28 April 2021 11:51 AM ISTMumbai: In order to accelerate and expand global access to Molnupiravir for treating Covid-19, Merck (known as MSD Pharmaceuticals outside the United...
